Nature Biotechnology
- 24, 885 - 887 (2006)
Published online: 3 August 2006; | doi:10.1038/nbt0806-885
Looking for solid ground along the Critical PathMark Ratner
Cambridge, Massachusetts
With an emphasis on diagnostics tools, the independently funded C-Path Institute aims to have a significant role in helping the FDA better oversee innovation. Mark Ratner reports.
MORE ARTICLES LIKE THIS These links to content published by NPG are automatically generated. NEWS AND VIEWSASCPT NewsClinical Pharmacology & Therapeutics News and Views
|
